Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Renal Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03457701
What this trial is testing

Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)

Who this might be right for
Anaemia
GlaxoSmithKline 15
Large-scale testing (Phase 3)Study completedNCT00261521
What this trial is testing

The Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients

Who this might be right for
Kidney Failure, ChronicAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 596
Not applicableStudy completedNCT00883415
What this trial is testing

Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease

Who this might be right for
CardiomyopathyChronic Kidney DiseaseAnemia
University of Maryland, Baltimore 20
Post-approval studies (Phase 4)Study completedNCT02817555
What this trial is testing

Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney Disease
Andrea L Woodland 50
Not applicableStudy completedNCT02950142
What this trial is testing

Evidence-based Laboratory Test Order Sets in Primary Care

Who this might be right for
Diabetes MellitusHypertensionCardiovascular Diseases+14 more
Universitaire Ziekenhuizen KU Leuven 288
Not applicableStudy completedNCT00211029
What this trial is testing

Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

Who this might be right for
Red-Cell Aplasia, Pure
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4,670
Large-scale testing (Phase 3)Study completedNCT00527137
What this trial is testing

NESP Pediatric Study

Who this might be right for
Pre-dialysisEnd Stage Renal Disease
Amgen 120
Large-scale testing (Phase 3)Study completedNCT05585645
What this trial is testing

Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD)

Who this might be right for
AnemiaChronic Kidney Disease Requiring Chronic Dialysis
Nanogen Pharmaceutical Biotechnology Joint Stock Company 214
Post-approval studies (Phase 4)Study completedNCT00922116
What this trial is testing

Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 191
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Post-approval studies (Phase 4)Study completedNCT00338000
What this trial is testing

EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure

Who this might be right for
Chronic Renal Failure
Janssen Pharmaceutica N.V., Belgium 292
Testing effectiveness (Phase 2)Study completedNCT02044653
What this trial is testing

Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

Who this might be right for
AnemiaChronic Kidney Disease
Genexine, Inc. 257
Large-scale testing (Phase 3)Study completedNCT05085275
What this trial is testing

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Who this might be right for
Anemia, Iron DeficiencyHyperphosphatemiaRenal Insufficiency, Chronic+4 more
USRC Kidney Research 289
Testing effectiveness (Phase 2)Ended earlyNCT00240734
What this trial is testing

Treatment of Anemia in Diabetic Subjects With CKD

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 11
Large-scale testing (Phase 3)Study completedNCT00440557
What this trial is testing

An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 375
Large-scale testing (Phase 3)Ended earlyNCT00701714
What this trial is testing

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

Who this might be right for
AnemiaChronic Renal Insufficiency
Sandoz 337
Large-scale testing (Phase 3)Looking for participantsNCT05970172
What this trial is testing

Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseRenal Anemia
Astellas Pharma Global Development, Inc. 100
Large-scale testing (Phase 3)Study completedNCT01478971
What this trial is testing

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

Who this might be right for
Chronic Kidney DiseaseAnemia
Takeda 184
Post-approval studies (Phase 4)Looking for participantsNCT06946394
What this trial is testing

Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI

Who this might be right for
Renal Anemia in Non-dialysis Chronic Kidney Disease
The First Affiliated Hospital of Dalian Medical University 160
Large-scale testing (Phase 3)Study completedNCT00536666
What this trial is testing

Iron Oligosaccharide in Chronic Kidney Disease Patients

Who this might be right for
Chronic Kidney DiseaseAnemia, Iron-Deficiency
Pharmacosmos A/S 182
Next Page